Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 1012 | 1095 | 1027 | 1122 | 1334 |
Fund Return | 1.92% | 1.23% | 9.51% | 0.88% | 2.33% | 2.92% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euro High Yield Class C EUR Cap | 2.78B | 1.40 | 0.98 | 3.31 | ||
Euro High Yield Class C EUR Dis | 2.78B | 1.38 | 0.93 | 3.22 | ||
Euro High Yield Class I EUR Cap | 2.78B | 2.36 | 1.69 | 3.69 | ||
Euro High Yield Class R EUR Cap | 2.78B | 2.28 | 1.74 | 3.77 | ||
Euro High Yield Class Z EUR Cap | 2.78B | 2.62 | 2.50 | 4.54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea 1 European High Yield Bond x | 2.84B | 1.70 | 1.27 | 3.94 | ||
N1 European High Yield Bond Fund AC | 2.84B | 2.44 | 0.77 | 3.10 | ||
LU0229519474 | 2.84B | 1.95 | -0.42 | 1.91 | ||
N1 European High Yield Bond Fund Ai | 2.84B | 2.53 | 0.96 | 3.32 | ||
N1 European High Yield Bond Fund Ae | 2.84B | 1.27 | 0.00 | 2.64 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Candriam Monétaire SICAV V C | FR0013113222 | 7.83 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | XS2406607171 | 4.15 | - | - | |
Nidda Healthcare Holding GmbH 7.5% | XS2550063478 | 2.96 | - | - | |
Lorca Telecom Bondco S.A.U. 4% | XS2240463674 | 2.81 | - | - | |
Picard Groupe S.A.S. 3.875% | XS2361342889 | 2.28 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review